Log In
Print
BCIQ
Print
Print this Print this
 

SYK inhibitors

  Manage Alerts
Collapse Summary General Information
Company Gilead Sciences Inc.
DescriptionSpleen tyrosine kinase (SYK) inhibitors
Molecular Target Spleen tyrosine kinase (SYK)
Mechanism of ActionSyk kinase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationRheumatoid arthritis (RA)
Indication DetailsTreat rheumatoid arthritis (RA)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today